Mirae Asset Global Investments Co. Ltd. Has $4.59 Million Stock Position in Medical Properties Trust, Inc. (NYSE:MPW)

Mirae Asset Global Investments Co. Ltd. lowered its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 6.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 933,742 shares of the real estate investment trust’s stock after selling 64,233 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned about 0.16% of Medical Properties Trust worth $4,585,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Prime Capital Investment Advisors LLC acquired a new stake in shares of Medical Properties Trust during the fourth quarter worth $81,000. International Assets Investment Management LLC increased its position in shares of Medical Properties Trust by 486.4% in the fourth quarter. International Assets Investment Management LLC now owns 836,090 shares of the real estate investment trust’s stock worth $4,105,000 after purchasing an additional 693,517 shares during the period. KG&L Capital Management LLC increased its position in shares of Medical Properties Trust by 95.5% in the fourth quarter. KG&L Capital Management LLC now owns 60,275 shares of the real estate investment trust’s stock worth $296,000 after purchasing an additional 29,450 shares during the period. Ballentine Partners LLC bought a new position in shares of Medical Properties Trust in the fourth quarter worth $130,000. Finally, Vanderbilt University bought a new position in shares of Medical Properties Trust in the fourth quarter worth $58,000. Institutional investors and hedge funds own 71.79% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on MPW shares. Deutsche Bank Aktiengesellschaft started coverage on Medical Properties Trust in a research report on Tuesday, January 30th. They issued a “sell” rating and a $2.00 price target on the stock. BNP Paribas upgraded Medical Properties Trust from a “neutral” rating to an “outperform” rating and set a $6.00 price target on the stock in a research report on Friday, March 1st. Royal Bank of Canada decreased their target price on Medical Properties Trust from $8.00 to $5.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 20th. KeyCorp reissued a “sector weight” rating on shares of Medical Properties Trust in a research note on Friday, January 5th. Finally, Colliers Securities downgraded Medical Properties Trust from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $10.00 to $4.25 in a research note on Wednesday, April 10th. Six investment analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $5.48.

Medical Properties Trust Stock Performance

Medical Properties Trust stock opened at $4.74 on Tuesday. The business has a 50 day moving average of $4.08 and a 200-day moving average of $4.37. Medical Properties Trust, Inc. has a 1 year low of $2.92 and a 1 year high of $10.74. The company has a debt-to-equity ratio of 1.32, a current ratio of 2.26 and a quick ratio of 2.26. The company has a market capitalization of $2.84 billion, a P/E ratio of -5.04, a P/E/G ratio of 1.18 and a beta of 1.20.

Medical Properties Trust Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 12.66%. The ex-dividend date is Friday, April 19th. Medical Properties Trust’s dividend payout ratio is currently -63.83%.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.